Home LiteratureArticle Details
PMID: 9733627 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Tumor necrosis factor binding protein improves incisional wound healing in sepsis.

The Journal of surgical research ·Vol. 78 ·No. 2 ·1998-08-00 ·Pages 108-17

Maish GO, Shumate ML, Ehrlich HP, Cooney RN

Abstract

Sepsis is associated with poor wound healing; however, the exact role of tumor necrosis factor (TNF) as a mediator of sepsis-induced alterations in different types of tissue repair is unknown. This study examines the effects of a specific TNF antagonist (TNFbp) on the healing of intestinal anastomoses, incisional wounds, and polyvinyl (PVA) sponge implants in chronic abdominal sepsis. Three groups of male Sprague-Dawley rats were studied: control, sepsis, and sepsis + TNFbp. Jejunal resection and anastomosis were performed through a 4-cm upper midline incision on day 1. On day 3, sepsis was induced by creation of a chronic abdominal abscess. Saline (0.1 ml) or TNFbp (1.0 mg/kg, 0.1 ml) was injected subcutaneously every day starting 4 h prior to sepsis. On day 7, the wound-breaking strength (WBS) of the skin incision and intestinal anastomoses was determined using a tensiometer. Wound histology and collagen deposition were evaluated by comparison of Sirius red-stained sections. The hydroxyproline content of PVA sponges was used to quantitate collagen content under the different experimental conditions. Septic mortality (20% vs 26%) was not significantly altered by TNFbp. Septic animals demonstrated a reduction in food consumption on days 3 to 5 that was not affected by TNFbp administration. Neither sepsis nor TNFbp altered the breaking strength or histologic appearance of intestinal anastomoses. However, the breaking strength of incisional wounds was decreased by 40% in septic rats (P < 0.001 vs controls). Administration of TNFbp to septic rats significantly improved incisional WBS (P < 0.01 vs sepsis), but not to control levels. Serius red staining of incisional wounds and PVA sponges demonstrated a decrease in collagen organization and deposition in septic rats that was ameliorated by TNFbp. Similarly, the reduction in hydroxyproline content of PVA sponges from septic animals was prevented by TNFbp. The process of tissue repair in intestine and skin wounds appears to be significantly different following the septic insult. The healing of jejunal anastomoses was refractory to the catabolic effects of sepsis. In contrast, collagen deposition and organization are significantly decreased in cutaneous wounds during chronic sepsis. TNFbp significantly ameliorated the inhibitory effects of sepsis on cutaneous wound healing. These results suggest that TNF is an important mediator of the decrease in collagen deposition observed in cutaneous wounds during the septic state.

MeSH Terms
Anastomosis, Surgical Animals Body Weight Chronic Disease Collagen/chemistry,metabolism Eating Hydroxyproline/analysis Jejunum/surgery Male Materials Testing Peritonitis/drug therapy,immunology,pathology Polyvinyls Postoperative Complications/microbiology Rats Rats, Sprague-Dawley Sepsis/drug therapy,immunology,pathology Surgical Sponges Tumor Necrosis Factor-alpha/immunology,pharmacology Wound Healing/immunology
Chemicals
Polyvinyls Tumor Necrosis Factor-alpha Collagen Hydroxyproline
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Maish G O
Department of Surgery, Pennsylvania State University-College of Medicine, Hershey, Pennsylvania, 17033, USA.
Shumate M L
Ehrlich H P
Cooney R N
Article Info
Journal
The Journal of surgical research
Abbr.
J Surg Res
ISSN
0022-4804
Published
1998-08-00
Pages
108-17
Language
English
Region
United States
NLM ID
0376340
Subset
IM
Grants
NIGMS NIH HHS · GM-55639A · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com